Long-awaited accolades for mRNA scientists Katalin Karikó and Drew Weissman (Image: Alex Gardner) Long-awaited accolades for mRNA scientists Katalin Karikó and Drew Weissman Katalin Karikó and Drew Weissman’s key mRNA discoveries more than 15 years earlier made COVID vaccines possible. Now the global public has opportunities to honor them.
‘In vivo’ RNA-based gene editing model for blood disorders developed Image: iStock/Ozgu Arslan ‘In vivo’ RNA-based gene editing model for blood disorders developed Researchers from Penn Medicine and The Children’s Hospital of Philadelphia show that gene editing tools can be delivered via lipid nanoparticles, which would reduce cost and increase access to cutting-edge gene therapies.
People with a conspiracy mindset resist childhood vaccination Image: iStock/Anna Rozhkova People with a conspiracy mindset resist childhood vaccination Research by Dan Romer and Kathleen Hall Jamieson of the Annenberg Public Policy Center explains the role that having a conspiracy mindset plays in adult reluctance to vaccinate children.
Putting biomedical research advances within reach Image: Courtesy of Penn Medicine Magazine Putting biomedical research advances within reach Treatments and vaccines are only useful in the hands of the people who need them, and Penn Medicine is working toward better access and equity for biomedical innovations.
A vaccine for pancreatic cancer? Deutsche Welle A vaccine for pancreatic cancer? Drew Weissman of the Perelman School of Medicine comments on the efficacy of a potential pancreatic cancer vaccine. Pancreatic cancer vaccine shows promise in small initial trial Scientific American Pancreatic cancer vaccine shows promise in small initial trial Drew Weissman of the Perelman School of Medicine is supportive of findings about a pancreatic cancer vaccine, though he says larger studies are needed to determine effectiveness. Why Penn research powers many FDA-approved treatments On August 30, 2017, faculty and staff at the Perelman Center for Advanced Medicine gathered for a “flash mob” celebration of the the FDA approval of a Penn Medicine-developed personalized cellular immune therapy. (Image: Courtesy of Penn Medicine News) Why Penn research powers many FDA-approved treatments Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications. Targeted prenatal therapy addresses long-standing gap in health equity Image: iStock/Motortion Targeted prenatal therapy addresses long-standing gap in health equity Penn engineers have developed a successful delivery system of mRNA to placental cells to treat preeclampsia at its root. New mRNA vaccine to fight 20 known subtypes of influenza Image: Bernard Chantal for Adobe Stock New mRNA vaccine to fight 20 known subtypes of influenza Heading into clinical trials, the new research from Penn Medicine may serve as a general preventative measure against future flu pandemics. Behind the scenes in the lab and the future of mRNA research Behind the scenes in the lab and the future of mRNA research Developing new vaccines and novel mRNA delivery methods, coupled with the satisfaction of mentoring and selfless dedication to medicine, inspire the work of scientists at the Weissman Lab. Load More
Pancreatic cancer vaccine shows promise in small initial trial Scientific American Pancreatic cancer vaccine shows promise in small initial trial Drew Weissman of the Perelman School of Medicine is supportive of findings about a pancreatic cancer vaccine, though he says larger studies are needed to determine effectiveness. Why Penn research powers many FDA-approved treatments On August 30, 2017, faculty and staff at the Perelman Center for Advanced Medicine gathered for a “flash mob” celebration of the the FDA approval of a Penn Medicine-developed personalized cellular immune therapy. (Image: Courtesy of Penn Medicine News) Why Penn research powers many FDA-approved treatments Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications. Targeted prenatal therapy addresses long-standing gap in health equity Image: iStock/Motortion Targeted prenatal therapy addresses long-standing gap in health equity Penn engineers have developed a successful delivery system of mRNA to placental cells to treat preeclampsia at its root. New mRNA vaccine to fight 20 known subtypes of influenza Image: Bernard Chantal for Adobe Stock New mRNA vaccine to fight 20 known subtypes of influenza Heading into clinical trials, the new research from Penn Medicine may serve as a general preventative measure against future flu pandemics. Behind the scenes in the lab and the future of mRNA research Behind the scenes in the lab and the future of mRNA research Developing new vaccines and novel mRNA delivery methods, coupled with the satisfaction of mentoring and selfless dedication to medicine, inspire the work of scientists at the Weissman Lab.
Why Penn research powers many FDA-approved treatments On August 30, 2017, faculty and staff at the Perelman Center for Advanced Medicine gathered for a “flash mob” celebration of the the FDA approval of a Penn Medicine-developed personalized cellular immune therapy. (Image: Courtesy of Penn Medicine News) Why Penn research powers many FDA-approved treatments Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications.
Targeted prenatal therapy addresses long-standing gap in health equity Image: iStock/Motortion Targeted prenatal therapy addresses long-standing gap in health equity Penn engineers have developed a successful delivery system of mRNA to placental cells to treat preeclampsia at its root.
New mRNA vaccine to fight 20 known subtypes of influenza Image: Bernard Chantal for Adobe Stock New mRNA vaccine to fight 20 known subtypes of influenza Heading into clinical trials, the new research from Penn Medicine may serve as a general preventative measure against future flu pandemics.
Behind the scenes in the lab and the future of mRNA research Behind the scenes in the lab and the future of mRNA research Developing new vaccines and novel mRNA delivery methods, coupled with the satisfaction of mentoring and selfless dedication to medicine, inspire the work of scientists at the Weissman Lab.